As first relayed by Bryan Hoch of MLB.com, the Yankees have promoted right-hander Dellin Betances from Triple-A Scranton/Wilkes-Barre and will have him pitch out of their big-league bullpen down the stretch. David Adams was optioned to the Triple-A level in a corresponding 25-man roster move.
Betances cracked Baseball America‘s Top 100 prospects list after both 2010 and 2011, but the 25-year-old never quite put it all together as a starter and finished the 2012 season with a rough 6.44 ERA and 1.85 WHIP in 131 1/3 minor league innings. He was moved to a bullpen role early this summer and has since flourished, boasting a 1.46 ERA and 63 strikeouts in 49 1/3 innings of relief as of his Sunday morning callup.
The native of Brooklyn, New York should do well as a long reliever in the Bronx.
MLB.com’s Brian McTaggart reports that Astros first baseman Jonathan Singleton has been suspended 100 games after testing positive for a drug of abuse for a third time. Minor league pitcher Dean Deetz has been suspended 80 games after testing positive for Dehydroclormethyltestosterone.
Singleton, 26, has had issues with marijuana in the past and opened up about his addiction several years ago. He said, “At this point it’s pretty evident to me that I’m a drug addict. I don’t openly tell everyone that, but it’s pretty apparent to myself.” He added, “I know that I enjoy smoking weed, I enjoy being high and I can’t block that out of my mind that I enjoy that. So I have to work against that.”
Singleton hasn’t played in the majors since 2015. Last season, after going all the way back to Double-A Corpus Christi, he hit .205/.376/.397 with 18 home runs and 62 RBI in 500 plate appearances.
Deetz, 24, was selected by the Astros in the 11th round of the 2014 draft. Between Corpus Christi and Triple-A Fresno last season, the right-hander posted a 4.25 ERA with a 97/50 K/BB ratio in 84 2/3 innings of work. He denies knowingly using a PED, per ESPN’s Keith Law.